Global Liquid Biopsy Market Assessment, By Product [Instruments, Kits and Consumables], By Technology [Single-gene Analysis Using PCR, Multi-gene Parallel Analysis Using NGS], By Sample Type [Blood/ Plasma, Others], By Circulating Biomarker [Circulating Tumor Cells, Cell-Free DNA, Circulating Tumor DNA, Extracellular Vesicles], By Application [Cancer Applications, Non-Cancer Applications, Organ Transplant, Infectious Disease Testing, Non-Invasive Prenatal Testing, Monitoring, Others], By Usage [Clinical Use, Research Use], By End-user [Hospitals, Diagnostic Laboratories, Academic and Research Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
Global liquid biopsy market is projected to experience significant growth over the forecast period owing to increasing preference for non-invasive diagnostic procedures and rising cases of cancer.
Home>Industry Reports>Global Liquid Biopsy Market Assessment, Opportunities and Forecast, 2017-2031F
Global liquid biopsy market is projected to witness a CAGR of 12.58% during the forecast period 2024-2031F, growing from USD 6.29 billion in 2023 to USD 16.23 billion in 2031F. The market's growth is supported by the increasing prevalence of cancer, the introduction of novel technologies, and rising investments in research and development activities.
Due to the various advantages offered by liquid biopsy, the applications of the technique are increasing. It offers convenience and tolerability for patients and has the potential to detect treatment resistance and disease progression long before the condition appears on imaging scans or triggers clinical symptoms. The non-invasive nature of liquid biopsies allows for easy disease management and boosts patient acceptability by allowing for easy and quick, repeatable tests.
The liquid biopsy assays approved so far by the different governing and regulatory bodies, including the United States Food and Drug Administration (US FDA), can be used for monitoring disease progression, identifying targeted treatments, and gauging the therapy response in patients with ovarian, breast, lung, colorectal, and prostate cancer, among other solid cancers.
Technological advancements in liquid biopsy are another major factor supporting the market's growth. An artificial intelligence (AI)-guided approach has shown significant sensitivity in predicting cancer recurrence, according to a new study published in the journal “Nature” in June 2024. The article showed that the machine learning model can detect circulating tumor DNA based on DNA sequencing data from blood tests of patients with high accuracy and sensitivity in patients with colorectal cancer, melanoma, lung cancer, precancerous colorectal polyps, and breast cancer.
Introduction of Novel Technologies Boosts Market Growth
The rising investments by various companies and startups towards introducing novel technologies are expected to bolster the global liquid biopsy market growth. For instance, Twist Bioscience Corp, one of the leading synthetic biology companies known for developing synthetic DNA-based products, launched a cfDNA library preparation kit for applications in liquid biopsy in February 2024. The kit is built to maximize the number of cfDNA molecules and increase confidence in the sensitivity and accuracy of liquid biopsy tests. The kit adds to the company’s portfolio of tools designed to support the research and development of liquid biopsy assays.
Such efforts have also supported the development of artificial intelligence-powered tools that are sensitive to predicting cancer recurrence. A team of scientists trained a machine learning model for analyzing ctDNA based on the DNA sequencing data from blood tests. The technology was tested in patients with colorectal cancer, breast cancer, lung cancer, precancerous colorectal polyps, and melanoma. It achieved a significant signal-to-noise enhancement, thus enabling the detection of cancer recurrence.
Increasing Prevalence of Cancer Supports Market Expansion
The rise in the number of cancer cases across the globe is one of the major factors boosting the global liquid biopsy market demand. According to the estimates of the World Health Organization (WHO), over 35 million new cases of cancer are expected to occur in 2050. This rise is providing lucrative growth opportunities to the market as liquid biopsies aid in tracking and identifying cancer non-invasively. Liquid biopsies also find applications in various stages of cancer management, including response monitoring, therapy selection, and early cancer identification. The advancements in liquid biopsy, such as next-generation sequencing (NGS) and digital polymerase chain reaction (dPCR), have aided in improving the specificity and sensitivity of biomarker identification. The popularity of liquid biopsy is increasing among physicians as it aids in identifying cancer at an early stage. They can also examine CTCs and ctDNA released in the circulation by tumors to determine tumor-specific markers and genetic changes linked with early-stage malignancies.
North America Accounts for Significant Market Share
The growth of the market in North America is supported by the strong presence of key market players and an advanced healthcare system, acceptance of new technologies, rising cases of cancer, and increasing investments in research and development activities. The National Cancer Institute (NIH) estimates that 2,001,140 new cancer cases will be diagnosed in the United States in 2024, and 611,720 individuals will die from the disease. Furthermore, the increasing investments towards upgrading healthcare technology and infrastructure in the United States provide lucrative growth opportunities to the market.
The introduction of new products by healthcare and biotechnology companies based in the region is further supporting the expansion of the market in North America. In June 2022, Caris Life Sciences, Inc., a leading molecular science and technology company known for delivering and developing innovative solutions for revolutionizing healthcare, introduced its Caris Assure liquid biopsy assay. The blood-based molecular profiling assay analyzes the whole transcriptome (cfRNA) and the whole exome (cfDNA) of 22,000 genes from a simple blood sample, including the Tumor Mutational Burden (TMB), Microsatellite Instability (MSI), and Loss of Heterozygosity (LOH).
Cancer Applications Account for Significant Liquid Biopsy Market Share
The increasing prevalence of different types of cancer and growing awareness about the various benefits offered by liquid biopsy are propelling the segment’s expansion. The non-invasive approach of liquid biopsies to manage and diagnose cancer is further bolstering the adoption of the technique for cancer applications. Additionally, due to the rise in the number of cases of colorectal cancer and the various advantages offered by liquid biopsy for colorectal cancer screening as compared to invasive methods such as colonoscopy and traditional non-invasive methods that include screening with a stool sample, liquid biopsy has the potential for integrating into clinical practice to manage and diagnose colorectal cancer effectively. According to the estimates of the Colorectal Cancer Alliance, approximately 150,000 Americans are diagnosed with colorectal cancer every year.
Furthermore, the rising research activities to develop blood tests that can accurately detect early-stage cancer further support the segment’s growth. A blood test was developed by the City of Hope Duarte Cancer Center researchers in California, United States, that analyzes small RNA bits released by the tumors. The study, which included 1,000 participants from various regions across the globe, showed that the test was able to detect late accurately- and early-stage pancreatic cancer in a diverse group of individuals.
Future Market Scenario (2024-2031F)
As per the global liquid biopsy market analysis, the market is expected to grow significantly in the coming years. Liquid biopsy has gained popularity over the past few years and has provided a repeatable and minimally invasive method of describing and detecting cancers. The procedure has the potential to transform cancer care by categorizing cancer-specific genomic alterations; this, in turn, aids in the identification of resistance markers, early detection, and residual assessment of diseases. Additionally, the rising investments in clinical trials to evaluate and determine the benefits of liquid biopsy are further expected to aid the expansion of the market. For instance, the Case Comprehensive Cancer Center in Cleaveland, Ohio, United States, is conducting a study to determine if liquid biopsy reduces the time for treatment of advanced nonsquamous non-small cell lung cancer. The interventional study is expected to conclude in August 2024.
Report Scope
“Liquid Biopsy Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global liquid biopsy market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 12.58% between 2024-2031F |
|
Revenue Forecast in 2031 |
USD 16.23 billion |
|
Segments Covered |
Product, Technology, Sample Type, Circulating Biomarker, Application, Usage, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profiled |
F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Illumina, Inc., Thermo Fisher Scientific Inc., Natera, Inc., Biocept, Inc., Myriad Genetics, Inc., Foundation Medicine |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global liquid biopsy market has been segmented into the following categories:
- By Product
- Instruments
- Kits and Consumables
- By Technology
- Single-Gene Analysis Using PCR
- Multi-Gene Parallel Analysis Using NGS
- By Sample Type
- Blood/Plasma
- Others
- By Circulating Biomarker
- Circulating Tumor Cells
- Cell-Free DNA
- Circulating Tumor DNA
- Extracellular Vesicles
- By Application
- Cancer Applications
- Breast Cancer
- Lung Cancer
- Gastric Cancer
- Prostate Cancer
- Melanoma
- Colorectal Cancer
- Others
- Non-Cancer Applications
- Organ Transplant
- Infectious Disease Testing
- Non-Invasive Prenatal Testing
- Monitoring
- Treatment Monitoring
- Recurrence Monitoring
- Others
- Cancer Applications
- By Usage
- Clinical Use
- Research Use
- By End-user
- Hospitals
- Diagnostic Laboratories
- Academic and Research Centers
- Others
- By Region
- North America
- South America
- Europe
- Asia-Pacific
- Middle East and Africa
Key Players Landscape and Outlook
Rising collaborations between companies and startups specializing in diagnostics and developing tumor treatments are bolstering the global liquid biopsy market size. In June 2024, EVIIVE and Ymmunobio AG announced a collaboration to develop an innovative liquid biopsy with the help of extracellular vesicles for enhancing precision in disease monitoring and detection. The collaboration aims to advance the field of precision medicine and enhance the efficacy and accuracy of patient monitoring and disease detection. The novel liquid biopsy will use the unique properties of extracellular vesicles to provide a precise and non-invasive diagnostic tool and bring forward the next generation of diagnostic assays for patients with cancer to provide them with more reliable treatment guidance. Such collaborations and partnerships showcase the commitment of different companies and startups toward improving patient outcomes and innovation by providing advanced therapeutic and diagnostic solutions.
Key Players Operating in the Global Liquid Biopsy Market are:
- Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Natera, Inc.
- Biocept, Inc.
- Myriad Genetics, Inc.
- Foundation Medicine
Markets and Data report answers the following questions:
- What is the current and future market size of the product/service in question globally or specific to different countries?
- How are the markets divided into different product/service segments and the market size and growth of each segment?
- What is the market potential of different product segments and their investment case?
- How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
- What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global liquid biopsy market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global Liquid Biopsy Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2.1.Instruments
4.2.2.Kits and Consumables
4.3. By Technology
4.3.1.Single-Gene Analysis Using PCR
4.3.2.Multi-Gene Parallel Analysis Using NGS
4.4. By Sample Type
4.4.1.Blood/Plasma
4.4.2.Others
4.5. By Circulating Biomarker
4.5.1.Circulating Tumor Cells
4.5.2.Cell-Free DNA
4.5.3.Circulating Tumor DNA
4.5.4.Extracellular Vesicles
4.6. By Application
4.6.1.Cancer Applications
4.6.1.1. Breast Cancer
4.6.1.2. Lung Cancer
4.6.1.3. Gastric Cancer
4.6.1.4. Prostate Cancer
4.6.1.5. Melanoma
4.6.1.6. Colorectal Cancer
4.6.1.7. Others
4.6.2.Non-Cancer Applications
4.6.3.Organ Transplant
4.6.4.Infectious Disease Testing
4.6.5.Non-Invasive Prenatal Testing
4.6.6.Monitoring
4.6.6.1. Treatment Monitoring
4.6.6.2. Recurrence Monitoring
4.6.7.Others
4.7. By Usage
4.7.1.Clinical Use
4.7.2.Research Use
4.8. By End-user
4.8.1.Hospitals
4.8.2.Diagnostic Laboratories
4.8.3.Academic and Research Centers
4.8.4.Others
4.9. By Region
4.9.1.North America
4.9.2.South America
4.9.3.Europe
4.9.4.Asia-Pacific
4.9.5.Middle East and Africa
4.10. By Company Market Share (%), 2023
5. Global Liquid Biopsy Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Product
5.1.2.1. Instruments
5.1.2.2. Kits and Consumables
5.1.3.By Technology
5.1.3.1. Single-Gene Analysis Using PCR
5.1.3.2. Multi-Gene Parallel Analysis Using NGS
5.1.4.By Sample Type
5.1.4.1. Blood/Plasma
5.1.4.2. Others
5.1.5.By Circulating Biomarker
5.1.5.1. Circulating Tumor Cells
5.1.5.2. Cell-Free DNA
5.1.5.3. Circulating Tumor DNA
5.1.5.4. Extracellular Vesicles
5.1.6.By Application
5.1.6.1. Cancer Applications
5.1.6.1.1. Breast Cancer
5.1.6.1.2. Lung Cancer
5.1.6.1.3. Gastric Cancer
5.1.6.1.4. Prostate Cancer
5.1.6.1.5. Melanoma
5.1.6.1.6. Colorectal Cancer
5.1.6.1.7. Others
5.1.6.2. Non-Cancer Applications
5.1.6.3. Organ Transplant
5.1.6.4. Infectious Disease Testing
5.1.6.5. Non-Invasive Prenatal Testing
5.1.6.6. Monitoring
5.1.6.6.1. Treatment Monitoring
5.1.6.6.2. Recurrence Monitoring
5.1.6.7. Others
5.1.7.By Usage
5.1.7.1. Clinical Use
5.1.7.2. Research Use
5.1.8.By End-user
5.1.8.1. Hospitals
5.1.8.2. Diagnostic Laboratories
5.1.8.3. Academic and Research Centers
5.1.8.4. Others
5.1.9.United States*
5.1.9.1. Market Size & Forecast
5.1.9.1.1. By Value
5.1.9.1.2. By Volume
5.1.9.2. By Product
5.1.9.2.1. Instruments
5.1.9.2.2. Kits and Consumables
5.1.9.3. By Technology
5.1.9.3.1. Single-Gene Analysis Using PCR
5.1.9.3.2. Multi-Gene Parallel Analysis Using NGS
5.1.9.4. By Sample Type
5.1.9.4.1. Blood/Plasma
5.1.9.4.2. Others
5.1.9.5. By Circulating Biomarker
5.1.9.5.1. Circulating Tumor Cells
5.1.9.5.2. Cell-Free DNA
5.1.9.5.3. Circulating Tumor DNA
5.1.9.5.4. Extracellular Vesicles
5.1.9.6. By Application
5.1.9.6.1. Cancer Applications
5.1.9.6.1.1. Breast Cancer
5.1.9.6.1.2. Lung Cancer
5.1.9.6.1.3. Gastric Cancer
5.1.9.6.1.4. Prostate Cancer
5.1.9.6.1.5. Melanoma
5.1.9.6.1.6. Colorectal Cancer
5.1.9.6.1.7. Others
5.1.9.6.2. Non-Cancer Applications
5.1.9.6.3. Organ Transplant
5.1.9.6.4. Infectious Disease Testing
5.1.9.6.5. Non-Invasive Prenatal Testing
5.1.9.6.6. Monitoring
5.1.9.6.6.1. Treatment Monitoring
5.1.9.6.6.2. Recurrence Monitoring
5.1.9.6.7. Others
5.1.9.7. By Usage
5.1.9.7.1. Clinical Use
5.1.9.7.2. Research Use
5.1.9.8. By End-user
5.1.9.8.1. Hospitals
5.1.9.8.2. Diagnostic Laboratories
5.1.9.8.3. Academic and Research Centers
5.1.9.8.3.1. Others
5.1.10. Canada
5.1.11. Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East and Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Product
6.2. By Technology
6.3. By Sample Type
6.4. By Circulating Biomarker
6.5. By Application
6.6. By Usage
6.7. By End-user
6.8. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1. Political Factors
7.4.2. Economic System
7.4.3. Social Implications
7.4.4. Technological Advancements
7.4.5. Environmental Impacts
7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1. Supplier Power
7.5.2. Buyer Power
7.5.3. Substitution Threat
7.5.4. Threat From New Entrant
7.5.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. F. Hoffmann-La Roche Ltd.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products and Services
13.1.4. Financials (As Reported)
13.1.5. Key Market Focus and Geographical Presence
13.1.6. Recent Developments
13.2. Guardant Health, Inc.
13.3. Bio-Rad Laboratories, Inc.
13.4. QIAGEN N.V.
13.5. Illumina, Inc.
13.6. Thermo Fisher Scientific Inc.
13.7. Natera, Inc.
13.8. Biocept, Inc.
13.9. Myriad Genetics, Inc.
13.10. Foundation Medicine
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 4. Global Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 5. Global Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 6. Global Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 7. Global Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 8. Global Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 9. Global Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 10. Global Liquid Biopsy Market Share (%), By Region, 2017-2031F
Figure 11. North America Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 12. North America Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 13. North America Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 14. North America Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 15. North America Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 16. North America Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 17. North America Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 18. North America Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 19. North America Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 20. North America Liquid Biopsy Market Share (%), By Country, 2017-2031F
Figure 21. United States Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 22. United States Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 23. United States Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 24. United States Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 25. United States Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 26. United States Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 27. United States Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 28. United States Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 29. United States Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 30. Canada Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 31. Canada Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 32. Canada Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 33. Canada Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 34. Canada Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 35. Canada Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 36. Canada Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 37. Canada Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 38. Canada Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 39. Mexico Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 40. Mexico Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 41. Mexico Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 42. Mexico Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 43. Mexico Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 44. Mexico Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 45. Mexico Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 46. Mexico Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 47. Mexico Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 48. Europe Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 49. Europe Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 50. Europe Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 51. Europe Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 52. Europe Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 53. Europe Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 54. Europe Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 55. Europe Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 56. Europe Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 57. Europe Liquid Biopsy Market Share (%), By Country, 2017-2031F
Figure 58. Germany Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 59. Germany Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 60. Germany Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 61. Germany Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 62. Germany Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 63. Germany Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 64. Germany Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 65. Germany Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 66. Germany Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 67. France Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 68. France Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 69. France Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 70. France Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 71. France Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 72. France Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 73. France Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 74. France Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 75. France Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 76. Italy Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 77. Italy Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 78. Italy Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 79. Italy Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 80. Italy Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 81. Italy Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 82. Italy Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 83. Italy Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 84. Italy Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 85. United Kingdom Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 86. United Kingdom Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 87. United Kingdom Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 88. United Kingdom Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 89. United Kingdom Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 90. United Kingdom Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 91. United Kingdom Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 92. United Kingdom Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 93. United Kingdom Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 94. Russia Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 95. Russia Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 96. Russia Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 97. Russia Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 98. Russia Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 99. Russia Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 100. Russia Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 101. Russia Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 102. Russia Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 103. Netherlands Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 104. Netherlands Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 105. Netherlands Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 106. Netherlands Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 107. Netherlands Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 108. Netherlands Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 109. Netherlands Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 110. Netherlands Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 111. Netherlands Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 112. Spain Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 113. Spain Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 114. Spain Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 115. Spain Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 116. Spain Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 117. Spain Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 118. Spain Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 119. Spain Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 120. Spain Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 121. Turkey Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 122. Turkey Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 123. Turkey Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 124. Turkey Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 125. Turkey Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 126. Turkey Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 127. Turkey Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 128. Turkey Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 129. Turkey Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 130. Poland Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 131. Poland Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 132. Poland Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 133. Poland Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 134. Poland Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 135. Poland Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 136. Poland Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 137. Poland Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 138. Poland Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 139. South America Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 140. South America Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 141. South America Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 142. South America Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 143. South America Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 144. South America Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 145. South America Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 146. South America Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 147. South America Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 148. South America Liquid Biopsy Market Share (%), By Country, 2017-2031F
Figure 149. Brazil Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 150. Brazil Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 151. Brazil Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 152. Brazil Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 153. Brazil Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 154. Brazil Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 155. Brazil Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 156. Brazil Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 157. Brazil Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 158. Argentina Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 159. Argentina Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 160. Argentina Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 161. Argentina Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 162. Argentina Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 163. Argentina Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 164. Argentina Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 165. Argentina Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 166. Argentina Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 167. Asia-Pacific Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 168. Asia-Pacific Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 169. Asia-Pacific Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 170. Asia-Pacific Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 171. Asia-Pacific Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 172. Asia-Pacific Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 173. Asia-Pacific Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 174. Asia-Pacific Liquid Biopsy Market Share (%), By Usage, In USD Billion, 2016-2030
Figure 175. Asia-Pacific Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 176. Asia-Pacific Liquid Biopsy Market Share (%), By Country, 2017-2031F
Figure 177. India Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 178. India Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 179. India Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 180. India Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 181. India Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 182. India Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 183. India Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 184. India Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 185. India Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 186. China Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 187. China Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 188. China Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 189. China Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 190. China Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 191. China Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 192. China Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 193. China Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 194. China Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 195. Japan Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 196. Japan Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 197. Japan Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 198. Japan Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 199. Japan Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 200. Japan Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 201. Japan Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 202. Japan Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 203. Japan Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 204. Australia Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 205. Australia Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 206. Australia Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 207. Australia Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 208. Australia Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 209. Australia Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 210. Australia Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 211. Australia Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 212. Australia Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 213. Vietnam Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 214. Vietnam Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 215. Vietnam Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 216. Vietnam Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 217. Vietnam Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 218. Vietnam Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 219. Vietnam Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 220. Vietnam Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 221. Vietnam Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 222. South Korea Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 223. South Korea Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 224. South Korea Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 225. South Korea Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 226. South Korea Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 227. South Korea Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 228. South Korea Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 229. South Korea Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 230. South Korea Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 231. Indonesia Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 232. Indonesia Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 233. Indonesia Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 234. Indonesia Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 235. Indonesia Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 236. Indonesia Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 237. Indonesia Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 238. Indonesia Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 239. Indonesia Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 240. Philippines Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 241. Philippines Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 242. Philippines Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 243. Philippines Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 244. Philippines Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 245. Philippines Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 246. Philippines Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 247. Philippines Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 248. Philippines Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 249. Middle East & Africa Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 250. Middle East & Africa Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 251. Middle East & Africa Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 252. Middle East & Africa Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 253. Middle East & Africa Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 254. Middle East & Africa Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 255. Middle East & Africa Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 256. Middle East & Africa Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 257. Middle East & Africa Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 258. Middle East & Africa Liquid Biopsy Market Share (%), By Country, 2017-2031F
Figure 259. Saudi Arabia Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 260. Saudi Arabia Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 261. Saudi Arabia Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 262. Saudi Arabia Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 263. Saudi Arabia Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 264. Saudi Arabia Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 265. Saudi Arabia Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 266. Saudi Arabia Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 267. Saudi Arabia Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 268. UAE Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 269. UAE Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 270. UAE Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 271. UAE Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 272. UAE Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 273. UAE Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 274. UAE Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 275. UAE Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 276. UAE Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 277. South Africa Liquid Biopsy Market, By Value, In USD Billion, 2017-2031F
Figure 278. South Africa Liquid Biopsy Market, By Volume, In Million Units, 2017-2031F
Figure 279. South Africa Liquid Biopsy Market Share (%), By Product, 2017-2031F
Figure 280. South Africa Liquid Biopsy Market Share (%), By Technology, 2017-2031F
Figure 281. South Africa Liquid Biopsy Market Share (%), By Sample Type, 2017-2031F
Figure 282. South Africa Liquid Biopsy Market Share (%), By Circulating Biomarker, 2017-2031F
Figure 283. South Africa Liquid Biopsy Market Share (%), By Application, 2017-2031F
Figure 284. South Africa Liquid Biopsy Market Share (%), By Usage, 2017-2031F
Figure 285. South Africa Liquid Biopsy Market Share (%), By End-user, 2017-2031F
Figure 286. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 287. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 288. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 289. By Circulating Biomarker Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 290. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 291. By Usage Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 292. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 293. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What regions are covered in the final report of the global liquid biopsy market?
Who are the key players operating in the global liquid biopsy market?
What are the major factors influencing the growth of the global liquid biopsy market?
What is the market size and growth rate of the global liquid biopsy market?
See Related Reports
Global Compression Therapy Market Assessment, Opportunities and Forecast, 2017-2031F
Global compression therapy market is anticipated to witness significant growth over the forecast period owing to increasing investments by various companies towards novel product launches and the rise in the number of sports-related injuries.....Read More
Published on
July 2024
4,500
Global Sex Reassignment Surgery Market Assessment, Opportunities and Forecast, 2017-2031F
The sex reassignment surgery market is expected to grow because of increasing developments in technology, rising awareness about identity acceptance, and rising popularity of gender-affirming surgeries.....Read More
Published on
July 2024
4,500
Global Automotive Green Tires Market Assessment, Opportunities and Forecast, 2017-2031F
Global automotive green tire market is expected to experience growth due to rising demand for electric vehicles, rapid trend of personalization, stringent regulations for reducing carbon emissions, and advancement in tire technology.....Read More
Published on
July 2024
4,500
Global Automotive Bushing Market Assessment, Opportunities and Forecast, 2017-2031F
Global automotive bushing market is expected to experience growth due to rise in automotive production, a rapid shift toward electric vehicles, high demand for luxurious vehicles, and an increase in the production of automotive bushing. ....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
